860549 | C24:1 Glucosyl(ß) Ceramide (d18:1/24:1(15Z))

D-glucosyl-ß-1,1'-N-nervonoyl-D-erythro-sphingosine

Powder

Size SKU Packaging Price
5mg 860549P-5mg 860549P-5mg 1 x 5mg $255.40
Base Price: ${originalprice|money}
Custom Packaging: (${concentration} @$4.00/ea. + $100) ${custompackagingtotal|money}
Packaging: ${concentration}
Item Total: ${totalprice|money}
(Sales Tax may apply)
Please select an option above.
${sku} - ${concentration}
C24:1 Glucosyl(ß) Ceramide (d18:1/24:1(15Z))

C24:1 Glucosyl(ß) Ceramide (d18:1/24:1(15Z))

D-glucosyl-ß-1,1'-N-nervonoyl-D-erythro-sphingosine

Hygroscopic
No
Light Sensitive
No
Molecular Formula
C48H91NO8
Percent Composition
C 71.15%, H 11.32%, N 1.73%, O 15.80%
Purity
>99%
Stability
1 Year
Storage Temperature
-20°C
CAS Number
887907-50-8
CAS Registry Number is a Registered Trademark of the American Chemical Society
Formula Weight
810.238
Exact Mass
809.674
Synonyms
GlcCer(d18:1/24:1(15Z))
Glucosyl(ß) Ceramide (d18:1/24:1(15Z))
D-glucosyl-ß-1,1' N-(15Z-tetracosenoyl)-D-erythro-sphingosineN-(15Z-tetracosenoyl)-1-ß-glucosyl-sphing-4-ene
C24:1 ß-D-glucosyl ceramide
110760

Li C, Song B, Santos PM, Butterfield LH. Hepatocellular cancer-derived alpha fetoprotein uptake reduces CD1 molecules on monocyte-derived dendritic cells. Cell Immunol. 2019 Jan;335:59-67. doi: 10.1016/j.cellimm.2018.10.011. Epub 2018 Nov 1.

 PubMed ID: 30392891

Snider JM, Trayssac M, Clarke CJ, Schwartz N, Snider AJ, Obeid LM, Luberto C, Hannun YA. Flux analysis reveals regulation of the sphingolipid network by doxorubicin in breast cancer cells. J Lipid Res. 2018 Dec 20. pii: jlr.M089714. doi: 10.1194/jlr.M089714. [Epub ahead of print]

 PubMed ID: 30573560

von Gerichten J, Schlosser K, Lamprecht D, Morace I, Eckhardt M, Wachten D, Jennemann R, Gröne HJ, Mack M, Sandhoff R. Diastereomer-specific quantification of bioactive hexosylceramides from bacteria and mammals. J Lipid Res. 2017 Jun;58(6):1247-1258. doi: 10.1194/jlr.D076190. Epub 2017 Apr 3.

PubMed ID: 28373486